Can Tumor Mutational Burden Guide Immunotherapy in Colorectal Cancer?
No abstract available (Source: Oncology Times)
Source: Oncology Times - June 20, 2022 Category: Cancer & Oncology Tags: News Source Type: research
Checkpoint Inhibitors as First-Line Therapy for Gastric Cancer
No abstract available (Source: Oncology Times)
Source: Oncology Times - June 20, 2022 Category: Cancer & Oncology Tags: News Source Type: research
TKIs Provide Optimal Second-Line Therapy in Hepatocellular Carcinoma
No abstract available (Source: Oncology Times)
Source: Oncology Times - June 20, 2022 Category: Cancer & Oncology Tags: News Source Type: research
Multidisciplinary Precision Extends Life in Oligometastatic Breast Cancer
No abstract available (Source: Oncology Times)
Source: Oncology Times - June 20, 2022 Category: Cancer & Oncology Tags: News Source Type: research
Patient-Reported Outcomes Support First-Line Pembrolizumab in TNBC
No abstract available (Source: Oncology Times)
Source: Oncology Times - June 20, 2022 Category: Cancer & Oncology Tags: News Source Type: research
Lower Screening Rates for Women Who Have Breast Cancer Along With MS
No abstract available (Source: Oncology Times)
Source: Oncology Times - June 20, 2022 Category: Cancer & Oncology Tags: News Source Type: research
Breast Cancer Trial Looks to Recruit Underserved Communities
No abstract available (Source: Oncology Times)
Source: Oncology Times - June 20, 2022 Category: Cancer & Oncology Tags: News Source Type: research
View From the Other Side of the Stethoscope: Bittersweet Healing
No abstract available (Source: Oncology Times)
Source: Oncology Times - June 20, 2022 Category: Cancer & Oncology Tags: Opinion Source Type: research
Lower Extremity Lymphedema Presence in Female Cancer Survivors
No abstract available (Source: Oncology Times)
Source: Oncology Times - June 20, 2022 Category: Cancer & Oncology Tags: CME/CNE Source Type: research
New Radiation Therapy Guidelines for Patients With Brain Metastases
No abstract available (Source: Oncology Times)
Source: Oncology Times - June 20, 2022 Category: Cancer & Oncology Tags: News Source Type: research
Infigratinib (Truseltiq®)
No abstract available (Source: Oncology Times)
Source: Oncology Times - June 20, 2022 Category: Cancer & Oncology Tags: Pharmacy Forum Source Type: research
New Therapeutic Target for Most Common Type of Pancreatic Cancer
No abstract available (Source: Oncology Times)
Source: Oncology Times - June 20, 2022 Category: Cancer & Oncology Tags: Oncologists Guide to Genomics Source Type: research
UpToDate®
No abstract available (Source: Oncology Times)
Source: Oncology Times - June 20, 2022 Category: Cancer & Oncology Tags: UpToDate Source Type: research
Adolescent & Young Adult Leukemia Survivors Have Shorter Life Span
No abstract available (Source: Oncology Times)
Source: Oncology Times - June 20, 2022 Category: Cancer & Oncology Tags: News Source Type: research
ACS CAN Forum Spotlights Solutions to Achieve Health Equity
No abstract available (Source: Oncology Times)
Source: Oncology Times - June 20, 2022 Category: Cancer & Oncology Tags: News Source Type: research
